Fig. 3
From: The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
Distribution of clinical trials by drug types and mechanisms
The total number of clinical trials would be more than 2466, as a clinical trial could have more than one drug type. Abbreviations: DDP-4, dipeptidyl peptidase-4; GLP-1 RA, glucagon-like peptide-1 receptor agonists; SGLT2, sodium-dependent glucose transporters 2; NPC1L1, Niemann-Pick C1 Like1; PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9